Adjuvant and first line chemotherapy use for endometrial cancer
Objective: The objective of this study was to describe patterns of utilization of cytotoxic, hormonal, and immunotherapy in patients with endometrial cancer in the adjuvant setting and at the time of first recurrence. Methods: We identified patients in the IBM MarketScan database with endometrial ca...
Saved in:
Main Authors: | Anne Knisely (Author), Yongmei Huang (Author), Yeran Li (Author), Vimalanand S. Prabhu (Author), Jason D. Wright (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Corrigendum to "Adjuvant and first line chemotherapy use for endometrial cancer" [Gynecol. Oncol. Rep. 41 (2022) 101002]
by: Anne Knisely, et al.
Published: (2023) -
Neoadjuvant chemotherapy for advanced stage endometrial cancer: A systematic review
by: Allan B. Huang, et al.
Published: (2021) -
The use of neoadjuvant chemotherapy in advanced endometrial cancer
by: L. Philp, et al.
Published: (2021) -
Chemotherapy adjuvant and chemotherapy-induced neutropenia
by: Yiu-Tai Li, et al.
Published: (2022) -
Adjuvant Therapy for Endometrial Cancer in the Era of Molecular Classification
by: Sumedha Gupta, et al.
Published: (2024)